{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lexington",
      "address_1": "65 Hayden Avenue",
      "reason_for_recall": "Presence of Particulate Matter; Glass particulates observed in vials",
      "address_2": "",
      "product_quantity": "179,870 vials",
      "code_info": "Lot Numbers:   Lot 950453F, Exp. 12/06/2013   Lot 090203F, Exp. 09/07/2014   Lot 201703F, Exp. 08/31/2015   Lot 201653F, Exp. 09/01/2015",
      "center_classification_date": "20140117",
      "distribution_pattern": "Nationwide",
      "state": "MA",
      "product_description": "Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA",
      "report_date": "20140129",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Cubist Pharmaceuticals, Inc.",
      "recall_number": "D-764-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "66041",
      "termination_date": "20150210",
      "more_code_info": "",
      "recall_initiation_date": "20130829",
      "postal_code": "02421-7994",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}